Impact of the depth of lipohypertrophy assessed by ultrasound on glycemic control in diabetic patients / 中华内分泌代谢杂志
Chinese Journal of Endocrinology and Metabolism
; (12): 1001-1003, 2021.
Article
en Zh
| WPRIM
| ID: wpr-911416
Biblioteca responsable:
WPRO
ABSTRACT
To evaluate the impact of the depth of lipohypertrophy on glycemic control in diabetic patients, 498 diabetic patients were recruited from July 2017 to July 2020 in the First Affiliated Hospital of Nanjing Medical University. Their demographic and clinical data were collected. Lipohypertrophy was assessed with ultrasound. 85.1%(424/498) of patients had lipohypertrophy. The average depth of lipohypertrophy was(5.62±2.49) mm. Compared with HbA 1C≤7%, patients with HbA 1C>7% had significantly higher proportion of lipohypertrophy with depth >5 mm(69.7% vs 81.3%, P<0.05). After adjusting potential confounders, the level of HbA 1C in patients with the depth of lipohypertrophy>5 mm was still significantly higher than those with the depth of lipohypertrophy≤5 mm( OR=1.716, 95% CI 1.104-2.668, P<0.05). The depth of lipohypertrophy may be an independent risk factor for suboptimal HbA 1C. However, prospective studies are still needed to confirm.
Texto completo:
1
Índice:
WPRIM
Tipo de estudio:
Observational_studies
/
Risk_factors_studies
Idioma:
Zh
Revista:
Chinese Journal of Endocrinology and Metabolism
Año:
2021
Tipo del documento:
Article